Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T14:16:18.504Z.
Calculation as of: 2026-10-06T14:16:18.504Z.
Quote observation: 2026-10-06T14:15:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 07daf27a5d98c2e6040b1a84eec716383e035dd1d7ed5c9da608703ba97b77ea
PEG RATIO
N/A
CervoMed Inc.
Market Cap
$29.44M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| CervoMed Inc. (CRVO) | $29.44M | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.41M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $28.35M | N/A |
| MDxHealth S.A. (MDXH)vs › | $31.10M | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.19M | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.60M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $31.46M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.62M | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $32.06M | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.86M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
